59293-11-7 Usage
Uses
Used in Organic Synthesis:
TETRAHYDRO-FURAN-2-CARBOXYLIC ACID HYDRAZIDE is used as a reagent for the preparation of various derivatives, contributing to the synthesis of complex organic molecules.
Used in Biochemical Research:
In biochemical research, TETRAHYDRO-FURAN-2-CARBOXYLIC ACID HYDRAZIDE is used as a building block for the development of pharmaceutical and agrochemical products, facilitating the creation of new compounds with potential therapeutic and agricultural applications.
Used in Analytical Chemistry:
TETRAHYDRO-FURAN-2-CARBOXYLIC ACID HYDRAZIDE is used as a complexing agent for the determination of trace metal ions in various samples, owing to its ability to form stable complexes with metal ions.
Used in Enzyme Inhibition:
TETRAHYDRO-FURAN-2-CARBOXYLIC ACID HYDRAZIDE is studied for its potential as an enzyme inhibitor, which could have implications in the development of drugs targeting specific enzymatic pathways.
Used in Antimicrobial Applications:
TETRAHYDRO-FURAN-2-CARBOXYLIC ACID HYDRAZIDE has been studied for its antimicrobial properties, indicating its potential use in combating microbial infections.
Used in Anticancer Applications:
TETRAHYDRO-FURAN-2-CARBOXYLIC ACID HYDRAZIDE is being investigated for its anticancer properties, suggesting its possible use in the development of cancer therapeutics.
Check Digit Verification of cas no
The CAS Registry Mumber 59293-11-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,2,9 and 3 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 59293-11:
(7*5)+(6*9)+(5*2)+(4*9)+(3*3)+(2*1)+(1*1)=147
147 % 10 = 7
So 59293-11-7 is a valid CAS Registry Number.
InChI:InChI=1/C5H10N2O2/c6-7-5(8)4-2-1-3-9-4/h4H,1-3,6H2,(H,7,8)
59293-11-7Relevant academic research and scientific papers
HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
-
Paragraph 1112, (2017/12/01)
Compounds of Formula I and Formula II, pharmaceutically acceptable salts thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
Substituted imidazo-[1,5-a][1,2,4]triazolo[1,5-d][1,4] benzodiazepine derivatives
-
Page/Page column 34, (2008/06/13)
The present invention is concerned with substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives of the following formula wherein the definition of substituents is described in the claims. This class of compounds shows high affinity
